SLC34A3
protein-codingsolute carrier family 34 member 3, the group of Solute carrier family 34
Gene summary
This gene encodes a member of SLC34A transporter family of proteins, and is expressed primarily in the kidney. It is involved in transporting phosphate into cells via sodium cotransport in the renal brush border membrane, and contributes to the maintenance of inorganic phosphate concentration in the kidney. Mutations in this gene are associated with hereditary hypophosphatemic rickets with hypercalciuria. Alternatively spliced transcript variants varying in the 5' UTR have been found for this gene.[provided by RefSeq, Apr 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009431
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009431
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009431
Submitter: Natera
Inheritance Pattern: SD
Disease ID:MONDO:0009431
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009431
Submitter: ClinGen
*SLC34A3* was first reported in relation to autosomal recessive hereditary hypophosphatemic rickets with hypercalciuria in 2006 (Bergwitz et al., PMID: 16358214; and Ichikawa et al., PMID: 16849419). This condition is characterized by hypophosphatemic rickets; hypercalciuria; kidney stones; bone anomalies (such as short stature, osteopenia and bone pain); abnormal circulating vitamin D concentration; and kidney stones. Thirteen variants (missense, nonsense, frameshift, and splicing) that have been reported in at least eight probands in three publications are included in this curation (PMIDs: 16358214, 16849419, 31440709). An *SLC34A3* biallelic mutant genotype has also segregated with disease in nine affected individuals from one family (PMID: 16358214). The maximum score for genetic evidence (12 points) has been reached. The mechanism of disease appears to be loss-of-function (PMIDs: 16358214, 16849419, 31440709). This gene-disease relationship is also supported by experimental evidence (expression, biochemical function, functional alteration, mouse model; PMIDs: 11880379, 19570882, 22159077). Expression-level evidence shows that the gene is expressed in the kidney. Biochemical functional evidence shows that reduced phosphate uptake has been seen in affected patient plasma. Experimental evidence in xenopus oocytes with the same mutations found in affected humans shows reduced/lack of expression of the protein. Mutant mice have reduced body weight and bone anomalies, corresponding to short stature and bone anomalies seen in humans. In summary, there is definitive evidence supporting the relationship between *SLC34A3* and autosomal recessive hereditary hypophosphatemic rickets with hypercalciuria. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Tubulopathy GCEP on the meeting date 11/17/2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0009431
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Renal
Intervention: Renal
Rationale: The condition can result in sequelae such as severe rickets, and supplementation (eg, with phosphate) can be effective to treat many sequelae
Comments: Heterozygotes may show mild manifestations
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC34A3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001177316.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 11 | 180 | 2 | 195 |
| missense | 3 | 18 | 339 | 31 | 2 | 393 |
| nonsense | 7 | 13 | 2 | 22 | ||
| start loss | 2 | 2 | ||||
| frameshift | 17 | 11 | 3 | 31 | ||
| splice donor/acceptor (+/-2bp) | 4 | 28 | 6 | 1 | 39 | |
| Total | 32 | 73 | 361 | 212 | 4 | 682 |
Highest pathogenic variant AF is 0.0007227801
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001170787.2 | 12 | MANE Select | |
| Ensembl | ENSP00000501114.1 | 12 | MANE Select | |
| RefSeq | NP_001170788.2 | 12 | Standard | |
| RefSeq | NP_543153.2 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transport of inorganic cations/anions and amino acids/oligopeptides
- SLC-mediated transmembrane transport
- Transport of small molecules
- Type II Na+/Pi cotransporters
- Sodium-coupled phosphate cotransporters
Biological Process
- sodium ion transport
- phosphate ion transport
- cellular phosphate ion homeostasis
- sodium ion transmembrane transport
- sodium-dependent phosphate transport
Molecular Function
- sodium:phosphate symporter activity
- sodium-dependent phosphate transmembrane transporter activity
Cellular Component
- plasma membrane
- brush border
- integral component of membrane
- apical plasma membrane
- brush border membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000538474
- Coding exons
- 12
- Length
- 5798
- Individuals with no LoFs
- 125486
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 212
- Defined
- 125699
- p
- 0.000848
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.29 | 466 | 394 | 1.18 | 0.0000271 | 3758 |
| Missense (PolyPhen) | 188 | 166.58 | 1.1286 | 1678 | ||
| Synonymous | -3.27 | 251 | 193 | 1.30 | 0.0000148 | 1367 |
| Loss of Function | 0.215 | 21 | 22.1 | 0.951 | 0.00000105 | 222 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00040 | 0.00037 | rare |
| Latino/Admixed American | 0.00083 | 0.00081 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.0012 | 0.0011 | notable |
| European (Non-Finnish) | 0.0012 | 0.0011 | notable |
| South Asian | 0.00062 | 0.00059 | rare |
| Other | 0.00083 | 0.00082 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane. Probably mediates 20-30% of the apical influx.;
- Disease
- DISEASE: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]: Autosomal recessive form of hypophosphatemia characterized by reduced renal phosphate reabsorption and rickets. Increased serum levels of 1,25-dihydroxyvitamin D lead to increase in urinary calcium excretion. {ECO:0000269|PubMed:16358214, ECO:0000269|PubMed:16358215}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- LoFtool
- 0.239
- RVIS EVS
- 0.41
- RVIS percentile EVS
- 76.54
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.770
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |